arkley, purdue pharma, ariad

REVERSED

1700 Chemical & Materials Engineering
1732 Ex Parte Thomsen et al 11/583,135 NAGUMO 102(b)/103(a) NIXON & VANDERHYE, PC EXAMINER LI, JUN

Anticipation does not, however, lie where it is necessary to pick and choose among various disclosures to find a description of the later-claimed invention. In re Arkley, 455 F.2d 586, 587-88 (CCPA 1972)

2400 Networking, Mulitplexing, Cable, and Security
2444 Ex Parte Loda 10/082,958 SIU 103(a) 37 C.F.R. § 41.50(b) 112(2) BACHMAN & LAPOINTE, P.C. c/o CPA Global EXAMINER BENGZON, GREG C

AFFIRMED-IN-PART

1700 Chemical & Materials Engineering
1788 Ex Parte Tysoe et al 10/672,623 PAK 102(e) GENERAL ELECTRIC COMPANY (PCPI) C/O FLETCHER YODER EXAMINER LE, HOA T

2600 Communications
2614 Ex Parte Creamer et al 10/740,701 HOFF 103(a) International Business Machines Corporation CAREY, RODRIGUEZ, GREENBERG & PAUL, LLP STEVEN M. GREENBERG EXAMINER TRAN, QUOC DUC

2618 Ex Parte Martino 10/947,853 WHITEHEAD, JR. 112(1)/103(a) Law Office of Scott C Harris Inc EXAMINER NGUYEN, SIMON

"[O]ne cannot disclose a forest in the original application, and then later pick a tree out of the forest and say here is my invention." Purdue Pharma L.P. v. Faulding Inc. 230 F.3d 1320, 1326 (2000) Rather the specification must provide some guides or "blade marks" that disclose the claimed invention "specifically, as something applicants actually invented." Ariad Pharm. Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1348 (Fed. Cir. 2010)
Purdue Pharma L.P. v. Faulding, Inc., 230 F.3d 1320, 56 USPQ2d 1481 (Fed. Cir. 2000) . . . . .2163, 2163.05 AFFIRMED

1600 Biotechnology and Organic Chemistry
1623 Ex Parte Antrim et al 11/184,989 MILLS 112(2)/102(b)/103(a)/obviousness-type double patenting FITCH, EVEN, TABIN & FLANNERY EXAMINER BLAND, LAYLA D

1627 Ex Parte Salamone et al 11/391,060 ADAMS 103(a) Bausch & Lomb Incorporated EXAMINER HUANG, GIGI GEORGIANA

1643 Ex Parte Swetledge 11/493,651 ADAMS 103(a) LITMAN LAW OFFICES, LTD. EXAMINER HARRIS, ALANA M

2100 Computer Architecture and Software
2113 Ex Parte Deaton 10/949,041 DANG 102(b) TEXAS INSTRUMENTS INCORPORATED EXAMINER MCCARTHY, CHRISTOPHER S

2188 Ex Parte Beuten et al 10/633,113 POTHIER 103(a) KENYON & KENYON LLP EXAMINER CHERY, MARDOCHEE

2600 Communications
2624 Ex Parte Foo et al 11/018,264 RUGGIERO 103(a) MOTOROLA MOBILITY, INC EXAMINER STREGE, JOHN B

2800 Semiconductors, Electrical and Optical Systems and Components
2871 Ex Parte Aufderheide et al 10/686,141 WHITEHEAD, JR. 103(a) 3M INNOVATIVE PROPERTIES COMPANY EXAMINER RUDE, TIMOTHY L

2885 Ex Parte Cleaver et al 10/771,174 KOHUT 103(a) FITCH EVEN TABIN & FLANNERY EXAMINER SAWHNEY, HARGOBIND
REHEARING

DENIED

2800 Semiconductors, Electrical and Optical Systems and Components
2833 Ex Parte Verdon et al 11/424,046 MANTIS MERCADER 103(a) GRIFFIN & SZIPL, PC EXAMINER COLLINS, JASON M

NEW

REVERSED

2444 Ex Parte Loda 10/082,958 SIU 103(a) 37 C.F.R. § 41.50(b) 112(2) BACHMAN & LAPOINTE, P.C. c/o CPA Global EXAMINER BENGZON, GREG C

2451 Ex Parte Nirkhe et al 10/017,469 DIXON 103(a) LEE & HAYES, PLLC EXAMINER DINH, KHANH Q

REEXAMINATION

REHEARING DENIED

2617 Ex Parte AVID IDENTIFICATION SYSTEMS, INC. 90/008,702 5,499,017 SIU dissent TORCZON 102(b)/103(a) Patent Owner DLA PIPER US LLP Third Party Requesters Marger Johnson & McCollom PC EXAMINER PEIKARI, BEHZAD original EXAMINER SWANN III, GLEN R

AFFIRMED

1638 Ex Parte Abad et al 11/982,700 GRIMES 102(b)/102(e)/112(1) Schwegman Lundberg & Woessner/ Monsanto EXAMINER KUMAR, VINOD

1762 Ex Parte Correll et al 11/114,336 GARRIS 102(b) AKZO NOBEL INC. EXAMINER NERANGIS, VICKEY MARIE

3627 Ex Parte Emde et al 11/323,954 DESHPANDE 103(a) SCHWEGMAN, LUNDBERG & WOESSNER, P.A. EXAMINER HAIDER, FAWAAD

2432 Ex Parte Hori 09/947,547 NAPPI 102(e) WESTERMAN, HATTORI, DANIELS & ADRIAN, LLP EXAMINER LANIER, BENJAMIN E

2432 Ex Parte Kim et al 10/128,839 SMITH 103(a) EXAMINER BARRON JR, GILBERTO